Darwin Global Management as of Dec. 31, 2020
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 12 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acceleron Pharma | 33.5 | $120M | 939k | 127.94 | |
| Fate Therapeutics (FATE) | 24.2 | $87M | 953k | 90.93 | |
| Mirati Therapeutics | 16.0 | $57M | 261k | 219.64 | |
| Bridgebio Pharma (BBIO) | 13.2 | $47M | 663k | 71.11 | |
| Sarepta Therapeutics (SRPT) | 5.5 | $20M | 115k | 170.49 | |
| Immunovant (IMVT) | 2.6 | $9.2M | 199k | 46.19 | |
| C4 Therapeutics Com Stk (CCCC) | 2.1 | $7.6M | 229k | 33.13 | |
| Generation Bio (GBIO) | 1.6 | $5.6M | 197k | 28.35 | |
| Arvinas Ord (ARVN) | 0.8 | $3.0M | 35k | 84.94 | |
| Inhibrx | 0.3 | $1.2M | 37k | 32.98 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $718k | 61k | 11.71 | |
| Stoke Therapeutics (STOK) | 0.1 | $372k | 6.0k | 62.00 |
